Saturday - April 19, 2025
National Institutes of Health's National Laboratory for Cancer Research: Drug Blocking Cancer-Driving RAS-PI3K Pathway Enters Clinical Trials
April 19, 2025
FREDERICK, Maryland, April 19 -- The National Institutes of Health's National Laboratory for Cancer Research issued the following news:

* * *

Drug blocking cancer-driving RAS-PI3K pathway enters clinical trials

Second drug candidate targeting RAS-related cancers developed in partnership to enter clinical trials

By Mary Ellen Hackett

A new investigational drug co-developed by Frederick National Laboratory for Cancer Research (F . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products